Wednesday, March 3, 2021

Cabotegravir Injection Can Protect Women From HIV for Two Months

›
An experimental injection drug works better than daily pills to protect women from getting  HIV  from an infected sex partner, researchers s...

FDA Approves Tepmetko (tepotinib) as the First and Only Once-daily Oral MET Inhibitor for Patients with Metastatic NSCLC with METex14 Skipping Alterations

›
EMD Serono, the healthcare business sector of Merck KGaA, Darmstadt, Germany in the US and Canada,  announced that the US Food and Drug Admi...
Tuesday, March 2, 2021

FDA Approves Cosela (trilaciclib) to Decrease the Incidence of Chemotherapy-Induced Myelosuppression

›
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, announced   the U.S. Food and Drug Administration (FDA)   approva...
Monday, March 1, 2021

FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45

›
In continuation of my update on antisense oligonucleotides   Sarepta Therapeutics, Inc. the leader in precision genetic medicine for rare d...
Wednesday, February 10, 2021

FDA Approves Klisyri (tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp

›
Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel th...
1 comment:
Tuesday, February 9, 2021

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer

›
Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced that the U.S. Food and...
Monday, February 8, 2021

FDA Approves Gemtesa (vibegron) Tablets for the Treatment of Patients with Overactive Bladder (OAB)

›
Urovant Sciences (Nasdaq: UROV) announced    the U.S. Food and Drug Administration (FDA)  approval of  the New Drug Application (NDA) for on...
Saturday, February 6, 2021

FDA Approves Orladeyo (berotralstat) as the First Oral, Once-Daily Therapy to Prevent Attacks in Hereditary Angioedema Patients

›
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)  announced the U.S. Food and Drug Administration (FDA) approval of  oral, once-daily Orladeyo ...
Friday, February 5, 2021

Oral Azacitidine Benefits Some Older Adults With AML

›
In continuation of my update on azacitidine  For older patients with acute myeloid leukemia (AML) who are in remission after chemotherapy, t...
Wednesday, February 3, 2021

Drug discovery study identifies promising new compound to open constricted airways

›
Despite the progress made in managing asthma and chronic obstructive pulmonary disease (COPD), poorly controlled symptoms for both respirato...
Monday, February 1, 2021

New drug form may help treat osteoporosis, calcium-related disorders

›
A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients...
Saturday, January 30, 2021

Sitagliptin Promising Addition for Preventing Acute GVHD

›
In continuation of my updates on  sitagliptin   For patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation, si...
Friday, January 29, 2021

Statins May Protect Heart From Chemo for Early Breast Cancer

›
In continuation of my update on statins  For women with early breast cancer treated with anthracyclines, statin exposure is associated with ...
Thursday, January 28, 2021

Alzheimer's disease drug may help fight against antibiotic resistance

›
In continuation of my update on PBT2 Researchers from The University of Queensland, The University of Melbourne and Griffith University have...